In March 2025, the company introduced new designs for the immediate-to-purchaser supplying of its Wegovy weight loss drug. The company proven a different pharmacy, known as NovoCare, which might cost buyers $499 per month for entry to the drug, fewer than half the cost of the drug as a result of